AHG · Bull vs Bear

The case for and the case against Akso Health Group, each point drawn from public SEC filings — who’s buying, the red flags, and the health score. No opinion, no price call. Read both sides, then pick yours.

the bull case // 2

Strong financial strength

Piotroski F 5/9 (7 measured)

SEC XBRL

Strong bankruptcy safety

Altman Z: safe zone

SEC XBRL

the bear case // 4

Earnings-manipulation risk

Beneish M-Score (9.06) is above the threshold — a screen for earnings-quality review, not an accusation (fast growers can trip it).

Short cash runway

Burning cash with roughly 0 months of runway — a dilutive raise looks likely.

Weak cash position

~0 months of cash left

SEC XBRL

Weak price momentum

-26.0% vs 200-day

SEC XBRL

where do you land on AHG?

Bull Bear

Saved on this device. Your call, from the evidence above — not a recommendation.

Educational only — not financial adviceand never a recommendation to buy or sell. Both sides are built from public SEC filings (Form 4, STOCK Act, 13F, XBRL financials), which lag 40–90 days; absence of a red flag is not a clean bill of health.